Fortnite Creator Rubius Gets His Own Skin In The Game The announcement about his new skin came from the creator himself, who ...

such as El Rubius, Ibai Llanos, Auronplay, among others. If you don't understand what is happening on this social network, don't worry that we are going to explain the context of this story.

Rubius Therapeutics has announced the pricing of its Nasdaq IPO, aiming to raise $200 million towards its novel cell therapies targeting cancer and autoimmune diseases. Based in Cambridge ...

Rubius Therapeutics was unable to secure financing to carry out its pivot to a new manufacturing process for its red blood cell-based cell therapies. The once high-flying biotech is now exploring ...

Here are the top 10 biggest streamers on Twitch, all are popular and influential personalities in the digital world.

An El Rubius Icon skin (via @Hypex) There’s a lot to look forward to in this update, even if much of it is unconfirmed right now. As for what’s locked in, though, there’s lots to get up to ...

LA man, 27, charged in El Sereno sex assault 27-year-old man in custody for kidnap, assault of teen in El Sereno Suspect sought in sex assault of teen at El Sereno park LA man, 27, charged in El ...

El Segundo Little League champs will ride on float in Rose Parade Parade honors El Segundo's Little League World Series champs El Segundo set to face Texas in US championship game of LLWS El ...

In the 16th and 17th centuries, Europeans believed that somewhere in the New World there was a place of immense wealth known as El Dorado. Their searches for this treasure wasted countless lives ...

El Taiger’s story has ended in tragedy. One week after the Cuban Reggaeton singer—whose real name was José Manuel Carbajal Zaldívar—was brought to the hospital after being found with a ...

MIAMI - Cuban reggaeton artist Jose Manuel Carbajal Zadivar, known professionally as El Taiger, died Thursday afternoon, seven days after he was found shot in the head in Miami. "During this ...

Rubius Therapeutics has announced the pricing of its Nasdaq IPO, aiming to raise $200 million towards its novel cell therapies targeting cancer and autoimmune diseases. Based in Cambridge ...